2021-01-06,TRACON Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
2020-12-30,TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China that was Submitted by its Corporate Partners Alphamab Oncology and 3D Medicines
2020-12-29,TRACON Pharmaceuticals Announces $5.0 Million Registered Direct Offering
2020-12-22,TRACON Pharmaceuticals Announces $8.8 Million Registered Direct Offering
2020-12-10,TRACON Pharmaceuticals Announces Dosing of First Patient in ENVASARC Pivotal Trial
2020-12-04,"Deere & Co, Chico's FAS, Aerpio Pharmaceuticals, TRACON Pharmaceuticals and Repligen Corp highlighted as Zacks Bull and Bear of the Day"
2020-12-03,3 Biotech Stocks to Buy on First Vaccine Approval Optimism
2020-11-30,Is TRACON Pharmaceuticals (TCON) A Good Stock To Buy Now?
2020-11-23,TRACON Announces Publication in Cancer Cell of Clinical Data that Provides Molecular Insight into the Mechanism of Action of TRC102 and Patient Populations Most Likely to Respond to Treatment
2020-11-16,TRACON Pharmaceuticals Announces Submission for Approval of Envafolimab (KN035) with the NMPA in China by its Corporate Partners Alphamab Oncology and 3D Medicines
2020-11-10,TRACON Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
2020-11-10,"TRACON Pharmaceuticals, Inc. to Host Earnings Call"
2020-11-03,"TRACON to Report Third Quarter 2020 Financial Results and Company Highlights on November 10, 2020"
2020-10-26,"TRACON Announces FDA Orphan Drug Designation for TRC102 in Malignant Glioma, Including Glioblastoma"
2020-09-25,Insider Buys TRACON Pharmaceuticals Shares
2020-09-21,TRACON Pharmaceuticals Highlights Updated Envafolimab Clinical Results in MSI-H/dMMR Colorectal Cancer
2020-09-10,TRACON Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
2020-09-09,Insider Buys TRACON Pharmaceuticals Shares
2020-09-03,TRACON Pharmaceuticals to Present at the Wells Fargo Virtual Healthcare Conference
2020-08-31,TRACON Pharmaceuticals Announces Additional $5.0 Million Private Placement
2020-08-27,TRACON Pharmaceuticals Announces $5.0 Million Private Placement
2020-08-25,Insider Buys TRACON Pharmaceuticals Stock
2020-08-24,Insider Buys TRACON Pharmaceuticals Shares
2020-08-17,Return On Capital Employed Overview: TRACON Pharmaceuticals
2020-08-17,TRACON Pharmaceuticals: Debt Overview
2020-08-17,TRACON Pharmaceuticals Announces FDA Clearance of ENVASARC Pivotal Trial
2020-08-05,TRACON Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
2020-08-03,TRACON Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
2020-07-29,"TRACON to Report Second Quarter 2020 Financial Results and Company Highlights on August 5, 2020"
2020-07-16,TRACON Pharmaceuticals Announces Filing of Protocol for ENVASARC Pivotal Trial with the FDA
2020-07-13,TRACON Pharmaceuticals to Host Key Opinion Leader Webinar on Envafolimab&#160;for the Treatment of Sarcoma
2020-06-22,Proactive Virtual Event Showcases Four Rising Stars of the Life Sciences Industry
2020-06-11,Edited Transcript of TCON earnings conference call or presentation 13-May-20 8:30pm GMT
2020-06-05,Should You Buy TRACON Pharmaceuticals Inc (TCON)?
2020-06-01,TRACON Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
2020-05-29,TRACON Pharmaceuticals Highlights Updated Envafolimab Results in MSI-H/dMMR Colorectal Cancer and Results from Clinical Trial of Opdivo and Yervoy Combination Therapy in Undifferentiated Pleomorphic Sarcoma Conducted by Alliance for Clinical Trials in Oncology
2020-05-14,TRACON Pharmaceuticals Announces Presentation of Positive Clinical Data for Envafolimab in MSI-H/dMMR Cancer at ASCO 2020 Virtual Scientific Program by its Corporate Partners 3D Medicines and Alphamab
2020-05-13,TRACON Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
2020-05-11,TRACON Pharmaceuticals Announces Successful Type B Meeting with FDAÂ for Pivotal Study of Envafolimab in Sarcoma
2020-05-06,"TRACON to Report First Quarter 2020 Financial Results and Company Highlights on May 13, 2020"
2020-04-24,TRACON Pharmaceuticals Retains Global Rights to TRC253 Following Completion of a Phase 1/2 Trial
2020-04-14,TRACON Pharmaceuticals Announces Appointment of Biotechnology Industry Veteran Shahe Garabedian as Senior Vice President of Quality Assurance and Granting of Inducement Award
2020-04-06,TRACON Announces May 8 Date for Type B Teleconference Meeting with FDA to Discuss Trial Design for ENVASARC: A Potential Pivotal Study of Envafolimab in Sarcoma
2020-03-19,TRACON Pharmaceuticals Announces Appointment of Saundra Pelletier to Board of Directors
2020-03-18,Edited Transcript of TCON earnings conference call or presentation 27-Feb-20 9:30pm GMT
2020-03-16,TRACON Announces Submission of Request for Type B Meeting with FDA to Discuss Trial Design for ENVASARC: A Potential Pivotal Study of Envafolimab in Sarcoma
2020-03-09,Santen and TRACON Discontinue Development of DE-122 for Wet Age-Related Macular Degeneration
2020-02-28,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO"
2020-02-27,TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update
2020-02-20,"TRACON to Report Fourth Quarter and Full Year 2019 Financial Results and Company Highlights on February 27, 2020"
2020-02-07,TRACON Pharmaceuticals Announces Change to Nasdaq Capital Market
2020-01-20,"Is TRACON Pharmaceuticals, Inc.'s (NASDAQ:TCON) CEO Pay Justified?"
2019-12-22,Should You Buy TRACON Pharmaceuticals Inc (NASDAQ:TCON)?
2019-12-20,Tracon stock rises on cancer development partnerships
2019-12-20,"TRACON Pharmaceuticals, 3D Medicines and Jiangsu Alphamab Announce Partnership for Development of Subcutaneous PD-L1 Single-Domain Antibody in Soft Tissue Sarcoma"
2019-11-21,Edited Transcript of TCON earnings conference call or presentation 5-Nov-19 9:30pm GMT
2019-11-08,TRACON Pharmaceuticals Announces Reverse Stock Split
2019-11-05,TRACON Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
2019-10-29,"TRACON to Report Third Quarter 2019 Company Highlights and Financial Results on November 5, 2019"
2019-10-21,"TRACON Pharmaceuticals Announces $15 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC"
2019-10-07,"TRACON Pharmaceuticals Announces that Scientific Advisor William Kaelin, Jr., M.D. was Awarded the 2019 Nobel Prize in Physiology or Medicine"
2019-09-03,TRACON Pharmaceuticals to Present at the Rodman & Renshaw 21st Annual Global Investment Conference Sponsored by H.C. Wainwright
2019-08-29,TRACON Pharmaceuticals to Present at the 2019 Wells Fargo Securities Healthcare Conference
2019-08-28,TRACON Pharmaceuticals to Present at the RHK Capital 4th annual Disruptive Growth Conference hosted by Reed Smith
2019-08-07,TRACON Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
2019-08-07,TRACON Pharmaceuticals to Participate in the 2019 BTIG Biotechnology Conference
2019-08-01,Tracon Pharma Shares Rally As First Patient Dosed In Cancer Trial
2019-08-01,I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in the U.S. Phase 1 Clinical Trial of the CD73 Antibody TJD5 in Patients with Advanced Solid Tumors
2019-07-31,"TRACON to Report Second Quarter 2019 Company Highlights and Financial Results on August 7, 2019"
2019-07-29,TRACON Pharmaceuticals to Participate in Wells Fargo Securities 2019 Biotech Corporate Access Day
2019-07-02,TRACON Pharmaceuticals Provides Update on Phase 1/2 Trial of TRC253 in Patients with Metastatic Castrate Resistant Prostate Cancer
2019-06-27,"Is TRACON Pharmaceuticals, Inc.'s (NASDAQ:TCON) Balance Sheet A Threat To Its Future?"
2019-06-07,"What Kind Of Shareholders Own TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)?"
2019-05-30,TRACON Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
2019-05-15,Edited Transcript of TCON earnings conference call or presentation 14-May-19 8:30pm GMT
2019-05-14,Tracon: 1Q Earnings Snapshot
2019-05-14,TRACON Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
2019-05-14,"TRACON Pharmaceuticals, Inc. to Host Earnings Call"
2019-05-07,"TRACON to Report First Quarter 2019 Company Highlights and Financial Results on May 14, 2019"
2019-04-12,"Bad news for Apple, Tracon slides, Boeing completes test flights"
2019-04-12,Tracon Pharmaceuticals shares slide 45% premarket after it ends trial of cancer treatment
2019-04-12,TRACON Pharmaceuticals Announces Termination of Phase 3 TAPPAS Trial Based on the Recommendation of the Independent Data Monitoring Committee
2019-03-27,"TRACON Pharmaceuticals Announces TRC105, TRC253 and TRC102 Data Presentations at Upcoming AACR Annual Meeting"
2019-03-07,"How Should Investors React To TRACON Pharmaceuticals, Inc.s (NASDAQ:TCON) CEO Pay?"
2019-03-01,Edited Transcript of TCON earnings conference call or presentation 28-Feb-19 9:30pm GMT
2019-02-28,TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
2019-02-28,"TRACON Pharmaceuticals, Inc. to Host Earnings Call"
2019-02-21,"TRACON to Report Fourth Quarter and Full Year 2018 Company Highlights and Financial Results on February 28, 2019"
2019-01-22,TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 in Hepatocellular Carcinoma
2018-12-31,"Analysis: Positioning to Benefit within PPL, Inseego, Scientific Games, Orgenesis, CUI Global, and TRACON Pharmaceuticals  Research Highlights Growth, Revenue, and Consolidated Results"
2018-12-27,"Stocks to Watch Before The Opening Bell on December 27, 2018"
2018-12-27,"The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede"
2018-12-26,TRACON Pharmaceuticals Presents Positive Top-line Clinical Data from Dose Escalation Portion of Phase 1 Trial of TRC105 and OpdivoÂ® for Treatment of Non-Small Cell Lung Cancer
2018-12-26,TRACON Pharmaceuticals Announces Submission of IND Application for TJ4309 (CD73 Antibody TJD5) for Treatment of Advanced Solid Tumors
2018-12-21,TRACON Pharmaceuticals Announces Top-line Data from Phase 2 TRAXAR Clinical Trial in Renal Cell Carcinoma
2018-12-04,TRACON Pharmaceuticals and I-Mab Biopharma Reschedule Conference Call to Discuss Strategic Partnerships for Multiple Immuno-Oncology Programs
2018-12-03,TRACON Pharmaceuticals and I-Mab Biopharma to Host Conference Call to Discuss Strategic Partnerships for Multiple Immuno-Oncology Programs
2018-11-29,TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs
2018-11-19,TRACON Pharmaceuticals Presents Data from Phase 2 Trial of TRC102 and TemodarÂ® in Patients with Recurrent Glioblastoma at Society for Neuro-Oncology Annual Meeting
2018-11-15,TRACON Pharmaceuticals Presents New Circulating Tumor Cell Data from Ongoing Pivotal Phase 3 TAPPAS Trial of TRC105 and VotrientÂ® in Patients with Angiosarcoma
